Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients

Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients

Abstract Background To compare the clinical value of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and pegylated rhG-CSF(PEG-rhG-CSF) in early-stage breast cancer (EBC) patients receiving adjuvant chemotherapy, compare the efficacy of PEG-rhG-CSF with different dose and explore t...

Full description

Bibliographic Details
Main Authors: Yantao Jiang, Ju Zhang, Jianxin Zhong, Hao Liao, Jiayang Zhang, Yaxin Liu, Yuehua Liang, Huiping Li
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Cancer
Subjects:
PEG-rhG-CSF
rhG-CSF
Breast cancer
Chemotherapy-induced- neutropenia
Febrile neutropenia
Online Access:https://doi.org/10.1186/s12885-023-11198-2

Internet

https://doi.org/10.1186/s12885-023-11198-2

Similar Items